World Solve

Some inequality is often seen as a natural result of differing effort or luck, but there's no agreed threshold for when it becomes unjust. Different political philosophies answer this question in fundamentally incompatible ways.

Some jurisdictions already use AI risk assessments to help judges decide sentences, raising concerns about fairness, bias, and accountability. Whether machines should have this level of influence over human freedom remains ethically unresolved.

Resources like fresh water, fertile soil, and certain minerals are being used faster than they can replenish, yet markets often don't price this depletion accurately. Building this cost into economic decision-making remains largely unresolved.

GDP growth doesn't capture things like wellbeing, environmental health, or inequality, yet it remains the default measure of a country's economic success. A broader, widely adopted alternative measure remains unsettled.

High-interest, exploitative loans continue to target people with limited financial options, often trapping them in cycles of debt. Stronger, consistently enforced protections against this remain incomplete in many regions.

As AI boosts productivity in many industries, the resulting financial gains tend to concentrate with business owners rather than being broadly shared. A fairer distribution mechanism remains a significant unresolved economic question.

Caregiving and household labor, disproportionately done by women, largely goes uncounted in standard economic measures like GDP. This makes an enormous amount of real economic contribution effectively invisible in policy decisions.

Sudden spikes in the price of staple commodities like wheat or rice can trigger food crises in import-dependent countries almost overnight. A more resilient global system to buffer these shocks remains unbuilt.

Trade deals can boost overall economic growth while still leaving specific groups of workers worse off, often in the same country. A consistent, fair way to support those workers remains politically unresolved.

Immigration policy varies enormously between countries, with no widely accepted standard for what fairness or humane treatment actually requires. This leaves migrants' treatment largely dependent on which country they happen to reach.

Surveillance capabilities often grow quietly, justified by security concerns, with limited public awareness or debate about their true scope. Building lasting oversight mechanisms remains a persistent democratic challenge.

Human trafficking networks exploit gaps between countries' laws and enforcement capacity, moving victims across borders largely undetected. A stronger, coordinated international strategy remains incomplete.

People displaced by climate disasters often don't qualify for legal refugee status under current international law, leaving them without clear protection. A modern framework addressing this gap remains unbuilt.

Wealthy interests can influence legislation through lobbying in ways ordinary citizens simply can't match, raising questions about whose interests policy actually serves. Balancing this influence remains a persistent unsolved governance issue.

Cryptocurrency regulation varies wildly by country, creating loopholes that enable fraud and money laundering to move freely across borders. A more consistent global approach remains politically difficult to achieve.

Some communities have lived with contaminated air, water, or soil for generations due to nearby industrial activity, with little formal compensation or cleanup. Establishing fair, enforceable accountability remains a persistent governance gap.

Early detection dramatically improves skin cancer survival rates, but many people lack easy access to dermatology screening. A cheap, widely available detection tool could catch far more cases before they become dangerous.

Postpartum depression affects many new parents, often going undiagnosed until it significantly affects their wellbeing and their child's early development. Better early prediction could allow support to begin before symptoms take hold.

Existing dementia treatments offer only modest, temporary relief from symptoms rather than meaningfully slowing the underlying disease. A real disease-modifying treatment remains one of medicine's most sought-after breakthroughs.

Genetic testing can reveal risk for serious inherited conditions, but cost and access limit it mostly to wealthier patients and countries. Broader affordability could catch preventable conditions far earlier for many more people.